Our research focuses on microbial pathogenesis, striving to understand the mechanisms by which viruses, bacteria, fungi, and parasites elicit pathogenesis in the infected host. Conversely, M&I researchers investigate the pathways by which the host immune response endeavors to overcome these infections. Investigation of preventative measures including the development of vaccines represents a part of our effort.
These studies are carried out in the laboratories of 32 primary faculty, 18 joint faculty and 11 research-track faculty who receive substantial research grant support from the NIH and other governmental and private agencies. In 2022, M&I received over $18 million in NIH grants and ranked #10 in NIH funding.
In 2020-22, our faculty published over 460 scientific articles in highly-ranked journals.
We have state-of-the-art facilities that include all of the equipment and resources necessary to perform this important research.